XML 39 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation Plans
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based compensation plans
NOTE 15 – STOCK-BASED COMPENSATION PLANS
The following table presents compensation expense and related tax benefits for all equity awards recognized in the consolidated statements of income:
 
2018
 
2017
 
2016
 
(in thousands)
Compensation expense
$
7,965

 
$
5,209

 
$
6,556

Tax benefit
(2,625
)
 
(3,994
)
 
(2,679
)
Stock-based compensation, net of tax
$
5,340

 
$
1,215

 
$
3,877



The tax benefits as a percentage of compensation expense, as shown in the preceding table, were 33.0%, 76.7% and 40.9% in 2018, 2017 and 2016, respectively. These percentages differ from the Corporation’s statutory tax rates of 21% for 2018 and 35% for 2017 and 2016 ("Tax Rates"). Tax benefits are only recognized over the vesting period for awards that ordinarily will generate a tax deduction when exercised, in the case of non-qualified stock options, or upon vesting, in the case of restricted stock, RSUs and PSUs. Tax benefits less than the Tax Rates resulted from incentive stock options, for which a tax benefit is not recognized during the vesting period. Tax benefits in excess of the Tax Rates resulted from incentive stock option exercises that triggered a tax deduction when they were exercised, and excess tax benefits realized on vesting RSUs and PSUs during the period.
The following table presents compensation expense and related tax benefits for restricted stock awards, RSUs and PSUs recognized in the consolidated statements of income, and included as a component of total stock-based compensation in the preceding table:
 
2018
 
2017
 
2016
 
(in thousands)
Compensation expense
$
7,124

 
$
4,922

 
$
6,165

Tax benefit
(1,585
)
 
(1,559
)
 
(2,158
)
Restricted stock compensation, net of tax
$
5,539

 
$
3,363

 
$
4,007


The following table provides information about stock option activity for the year ended December 31, 2018:
 
Stock
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(in millions)
Outstanding and exercisable as of December 31, 2017
878,202

 
$
10.66

 
 
 
 
Exercised
(214,845
)
 
10.29

 
 
 
 
Forfeited
(1,117
)
 
9.84

 
 
 
 
Expired
(3,472
)
 
9.78

 
 
 
 
Outstanding and exercisable as of December 31, 2018
658,768

 
$
10.75

 
4.1 years
 
$
3.0

Exercisable as of December 31, 2018
658,768

 
$
10.75

 
4.1 years
 
$
3.0



The following table provides information about nonvested restricted stock, RSUs and PSUs granted under the Employee Equity Plan and Directors' Plan for the year ended December 31, 2018:
 
 
Restricted Stock/RSUs/PSUs(1)
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Nonvested as of December 31, 2017
 
1,306,937

 
$
13.91

Granted
 
536,172

 
17.15

Vested
 
(438,596
)
 
12.76

Forfeited
 
(36,020
)
 
16.18

Nonvested as of December 31, 2018
 
1,368,493

 
$
15.49



(1) There were no nonvested stock options at December 31, 2018 or 2017.

As of December 31, 2018, there was $7.4 million of total unrecognized compensation cost (pre-tax) related to restricted stock, RSUs and PSUs that will be recognized as compensation expense over a weighted average period of two years. As of December 31, 2018, the Employee Equity Plan had 10.5 million shares reserved for future grants through 2023, and the Directors’ Plan had 312,000 shares reserved for future grants through 2021.

The following table presents information about stock options exercised:
 
2018
 
2017
 
2016
 
(dollars in thousands)
Number of options exercised
214,845

 
411,292

 
920,924

Total intrinsic value of options exercised
$
1,616

 
$
2,955

 
$
4,619

Cash received from options exercised
$
2,210

 
$
4,644

 
$
10,240

Tax deduction realized from options exercised
$
1,386

 
$
2,825

 
$
4,328


Upon exercise, the Corporation issues shares from its authorized, but unissued, common stock to satisfy the options.
The fair value of certain PSUs with market-based performance conditions granted under the Employee Equity Plan was estimated on the grant date using the Monte Carlo valuation methodology performed by a third-party valuation expert. This valuation is dependent upon certain assumptions, as summarized in the following table:
 
2018

 
2017

 
2016

Risk-free interest rate
2.63
%
 
1.43
%
 
0.92
%
Volatility of Corporation’s stock
23.50
%
 
22.45
%
 
20.75
%
Expected life of PSUs
3 Years

 
3 Years

 
3 Years



The expected life of the PSUs with fair values measured using the Monte Carlo valuation methodology was based on the defined performance period of three years. Volatility of the Corporation’s stock was based on historical volatility for the period commensurate with the expected life of the PSUs. The risk-free interest rate is the zero-coupon U.S. Treasury rate commensurate with the expected life of the PSUs on the date of the grant. Based on the assumptions above, the Corporation calculated an estimated fair value per PSU with market-based performance conditions granted in 2018, 2017 and 2016 of $12.92, $17.25 and $11.23, respectively.

Under the ESPP, eligible employees can purchase stock of the Corporation at 85% of the fair market value of the stock on the date of purchase. The ESPP is considered to be a compensatory plan and, as such, compensation expense is recognized for the 15% discount on shares purchased. The following table summarizes activity under the ESPP:
 
2018
 
2017
 
2016
ESPP shares purchased
110,200

 
98,000

 
109,665

Average purchase price per share (85% of market value)
$
14.74

 
$
15.28

 
$
12.37

Compensation expense recognized (in thousands)
$
287

 
$
261

 
$
240